Collectively, our findings indicate that MLT improves lysosomal damage in renal tubular epithelial cells through TFEB and its downstream pathways, such as the miR-205-LRP-1 pathway, and ultimately contributes to the delayed progression of DKD. Here, TFEB is linked to diabetic kidney disease.